Please keep checking this site for possible updates.

Video: “Imaging Tests”

by jroth on August 23, 2016

July 2016 Awareness Night Imaging Tests Dr. Masoom Haider, MD, FRCPC Senior scientist, Physical Sciences, Odette Cancer Research Program Sunnybrook Research Institute Chief, Department of medical imaging, Sunnybrook Health Sciences Centre Professor, Department of medical imaging, University of Toronto Clinician scientist, Ontario Institute for Cancer Research   CLICK ON THE ARROW TO START THE VIDEO […]

{ 0 comments }

Some research suggests that drinking pomegranate juice may slow the progression of prostate cancer Read the article.

{ 0 comments }

Questions to Ask Before Participating in a Prostate Cancer Clinical Trial

July 24, 2016

Several key questions that a participant will want answered before enrolling in a clinical trial are listed here. It is important that people learn as much as possible prior to entering a trial, and to thoroughly discuss the study with a doctor and with the study team. Read the article.

Read the article or watch the video →

Extended lymph node dissection in robotic radical prostatectomy

July 24, 2016

Studies have shown that radical prostatectomy can improve progression-free and overall survival in patients with lymph node-positive prostate cancer. While this finding requires further validation, it does allow urologists to question the former treatment paradigm of aborting surgery when lymph node invasion from prostate cancer occurred, especially in patients with limited lymph node tumor infiltration. […]

Read the article or watch the video →

Revolutionary new drug could help sex lives of thousands of prostate cancer suffers

July 24, 2016

A revolutionary new light activated drug will spare thousands of men with prostate cancer from the misery of ruined sex lives. The treatment involves injecting a light sensitive drug into the blood stream. When infra red light is shone on the prostate, it destroys the blood vessels feeding the tumour, killing it. Read the article.

Read the article or watch the video →

Study Suggests Chemotherapy After Radical Prostatectomy May Benefit Men Who Are At High Risk for Relapse

July 24, 2016

Not all men with prostate cancer benefit from adjuvant chemotherapy after radical prostatectomy; however, African American men and men with a higher tumor stage may, according to a new U.S. Department of Veterans Affairs (VA) study. Read the article.

Read the article or watch the video →

Landmark PSA Screening Trial Results Challenged

July 24, 2016

Recommendations against routine PSA screening from the US Preventive Services Task Force (USPSTF) are based largely on a landmark trial showing that such screening does not decrease the risk of death from prostate cancer (PCa), but this conclusion may be invalid. Read the article.

Read the article or watch the video →

Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy

July 24, 2016

A study evaluated experience with salvage brachytherapy after discovery of biochemical recurrence after a prior brachytherapy procedure. Twenty-one patients treated by brachytherapy within University of Kentucky or from outside centers developed biochemical failure and had no evidence of metastases. Conclusions. Salvage brachytherapy after primary brachytherapy is possible; however, the side-effect profile after the second brachytherapy […]

Read the article or watch the video →

SBRT for prostate cancer treatment offers higher cure rate than many traditional approaches

July 24, 2016

A five-year study shows that Stereotactic Body Radiation Therapy (SBRT) to treat prostate cancer offers a higher cure rate than more traditional approaches. The study – the first trial to publish five-year results from SBRT treatment for prostate cancer – found a 98.6 percent cure rate with SBRT, a noninvasive form of radiation treatment that […]

Read the article or watch the video →

Feasibility for active surveillance in biopsy Gleason 3 + 4 prostate cancer: an Australian radical prostatectomy cohort.

July 24, 2016

To examine the feasibility of active surveillance for low volume Gleason sum (GS) 3 + 4 disease compared to GS 3 + 3 disease. Retrospective review of 929 patients, with biopsy proven GS 3 + 3 and 3 + 4 PCa, undergoing upfront radical prostatectomy (RP) was performed. Read the article.

Read the article or watch the video →